Our blood proteome and miRNA analyses identified several RNF213 mutation-associated changes; for example, the increase in the concentration of a heart-enriched miRNA miR-499a-5p in MMD patient plasma (Table 2). Here, RNF213 is linked to multiminicore myopathy.